Novadaq Technologies Stock Company Profile

Description

Novadaq Technologies Inc. develops, manufactures, and markets fluorescence imaging products for use by surgeons in the operating room and other clinical settings in the United States and internationally. Its proprietary imaging platform is used to visualize blood vessels, nerves, and the lymphatic system during surgical procedures. The company offers SPY Elite imaging system for use in coronary artery bypass, cardiovascular, plastic, reconstructive, micro, organ transplant, and gastrointestinal surgeries; and PINPOINT endoscopic fluorescence imaging system, high-definition white-light video with SPY fluorescence imaging. It also provides Firefly systems for use in robotic surgery; LUNA fluorescence angiography that enables clinicians to visually assess tissue perfusion in various cardiovascular procedures; CO2 heart laser system for transmyocardial revascularization; and DermACELL tissue products for use in breast reconstruction surgeries, as well as in the treatment of diabetic foot, venous stasis ulcers, and chronic non-healing wounds. In addition, the company markets SPY Analysis Toolkit, a post-processing software that allows physicians to enhance and apply objective analysis tools to SPY Elite and LUNA images. Novadaq Technologies Inc. was founded in 2000 and is headquartered in Mississauga, Canada.